Parkman Healthcare Partners’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.71M | Sell |
150,373
-24,203
| -14% | -$758K | 0.54% | 63 |
|
|
2025
Q1 | $5.86M | Sell |
174,576
-18,428
| -10% | -$618K | 0.69% | 47 |
|
|
2024
Q4 | $7.57M | Buy |
193,004
+1,346
| +0.7% | +$52.8K | 1.01% | 38 |
|
|
2024
Q3 | $7.55M | Sell |
191,658
-17,632
| -8% | -$694K | 0.96% | 39 |
|
|
2024
Q2 | $8.16M | Sell |
209,290
-14,652
| -7% | -$571K | 1.09% | 36 |
|
|
2024
Q1 | $9.64M | Sell |
223,942
-70,846
| -24% | -$3.05M | 1.18% | 33 |
|
|
2023
Q4 | $13.6M | Buy |
294,788
+78,144
| +36% | +$3.6M | 1.91% | 18 |
|
|
2023
Q3 | $7.4M | Sell |
216,644
-1,096
| -0.5% | -$37.4K | 1.36% | 24 |
|
|
2023
Q2 | $8.38M | Sell |
217,740
-59,543
| -21% | -$2.29M | 1.45% | 23 |
|
|
2023
Q1 | $9.92M | Buy |
277,283
+41,792
| +18% | +$1.5M | 2.16% | 12 |
|
|
2022
Q4 | $9.29M | Buy |
235,491
+12,894
| +6% | +$508K | 2.47% | 10 |
|
|
2022
Q3 | $8.04M | Sell |
222,597
-71,962
| -24% | -$2.6M | 2.28% | 12 |
|
|
2022
Q2 | $8.96M | Sell |
294,559
-9,627
| -3% | -$293K | 3.3% | 5 |
|
|
2022
Q1 | $9.3M | Sell |
304,186
-56,316
| -16% | -$1.72M | 2.72% | 10 |
|
|
2021
Q4 | $11.3M | Buy |
360,502
+49,295
| +16% | +$1.54M | 2.49% | 12 |
|
|
2021
Q3 | $4.76M | Sell |
311,207
-90,000
| -22% | -$1.38M | 1.2% | 26 |
|
|
2021
Q2 | $7.47M | Buy |
401,207
+26,812
| +7% | +$499K | 1.63% | 19 |
|
|
2021
Q1 | $6.7M | Buy |
374,395
+12,706
| +4% | +$227K | 1.56% | 20 |
|
|
2020
Q4 | $5.56M | Sell |
361,689
-103,136
| -22% | -$1.59M | 1.43% | 29 |
|
|
2020
Q3 | $5.15M | Sell |
464,825
-125,442
| -21% | -$1.39M | 1.36% | 32 |
|
|
2020
Q2 | $7.4M | Hold |
590,267
| – | – | 2.09% | 14 |
|
|
2020
Q1 | $6.69M | Buy |
590,267
+2,208
| +0.4% | +$25K | 3.1% | 8 |
|
|
2019
Q4 | $7.71M | Buy |
+588,059
| New | +$7.71M | 2.23% | 16 |
|